Technologies
Should Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) Revive After A -10.88% Drop From Highs?
During the last session, Vertex Pharmaceuticals, Inc (NASDAQ:VRTX)’s traded shares were 0.89 million, with the beta value of the company hitting 0.44. At the end
